Feature Channels:

Alzheimer's and Dementia

Add to Favorites Subscribe Share
Signature-Vertical.png

Study Uncovers Unexpected Connection Between Gliomas, Neurodegenerative Diseases

Michigan Medicine - University of Michigan

New basic science and clinical research identifies TAU, the same protein studied in the development of Alzheimer’s, as a biomarker for glioma development.

Channels: Alzheimer's and Dementia, Cancer, Healthcare, Neuro, National Institutes of Health (NIH),

Released:
22-Jan-2020 7:20 PM EST
Embargo will expire:
24-Jan-2020 11:00 AM EST
Released to reporters:
22-Jan-2020 1:30 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Jan-2020 11:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results
MSU-Wordmark-Green-120-pxls.gif

Are bigger brains better?

Michigan State University

When it comes to certain parts of the brain, bigger doesn’t necessarily equate to better memory. According to a new study led by Michigan State University, a larger hippocampus, a curved, seahorse-shaped structure embedded deep in the brain, does not always reliably predict learning and memory abilities in older adults.

Channels: All Journal News, Alzheimer's and Dementia, Neuro,

Released:
16-Jan-2020 2:05 PM EST
Research Results

Special delivery: McMaster physicists design ‘super-human’ red blood cells to deliver drugs to specific targets within the body

McMaster University

A team of physicists from McMaster University has developed a process to modify red blood cells so they can be used to distribute drugs throughout the body, which could specifically target infections or treat catastrophic diseases such as cancer or Alzheimer’s.

Channels: All Journal News, Alzheimer's and Dementia, Blood, Cancer, Cell Biology, Pharmaceuticals,

Released:
16-Jan-2020 8:05 AM EST
Research Results
Newswise: Pathogenic Alzheimer’s disease cascade is activated by faulty norepinephrine signaling
  • Embargo expired:
    15-Jan-2020 2:00 PM EST

Pathogenic Alzheimer’s disease cascade is activated by faulty norepinephrine signaling

University of Alabama at Birmingham

Preclinical research has revealed a key missing piece of the Alzheimer’s disease puzzle. That allowed proof-of-concept experiments — using an existing drug — that dramatically reduced Alzheimer’s pathology and symptoms in mouse models, potentially offering an immediate treatment for this disease.

Channels: Alzheimer's and Dementia, Genetics, Neuro, Pharmaceuticals, National Institutes of Health (NIH), All Journal News,

Released:
15-Jan-2020 10:50 AM EST
Research Results
mmc-logo.gif

Estudio de Mayo Clinic descubre interruptor molecular para reparar trastornos del sistema nervioso central

Mayo Clinic

Un interruptor molecular es capaz de encender, en animales, una sustancia que repara el daño neurológico de trastornos como la esclerosis múltiple, descubrió un estudio de Mayo Clinic.

Channels: Alzheimer's and Dementia, Genetics, Healthcare, Neuro, All Journal News,

Released:
14-Jan-2020 11:15 AM EST
Research Results
Newswise: Scientists identify protein associated with ovarian cancer that exacerbates neurodegeneration in Alzheimer’s

Scientists identify protein associated with ovarian cancer that exacerbates neurodegeneration in Alzheimer’s

Houston Methodist

Houston Methodist scientists identified a protein found in ovarian cancer that may contribute to declining brain function and Alzheimer’s disease, by combining computational methods and lab research.

Channels: All Journal News, Alzheimer's and Dementia, Cancer, Neuro, Women's Health, Cell Biology,

Released:
13-Jan-2020 5:40 AM EST
Research Results
Newswise: Antibiotics could be promising treatment for form of dementia

Antibiotics could be promising treatment for form of dementia

University of Kentucky

Researchers at the University of Kentucky’s College of Medicine have found that a class of antibiotics called aminoglycosides could be a promising treatment for frontotemporal dementia.

Channels: All Journal News, Alzheimer's and Dementia, Neuro, Pharmaceuticals,

Released:
10-Jan-2020 8:35 AM EST
Research Results
Newswise: Study to examine biomarkers, economic factors that may increase risk for cognitive decline

Study to examine biomarkers, economic factors that may increase risk for cognitive decline

Iowa State University

An image of your retina may help determine your risk for Alzheimer’s disease even before other symptoms are detectable. Iowa State researchers will use the retinal images, cognitive measurements and economic data to determine if this information can identify risk for Alzheimer’s disease.

Channels: Alzheimer's and Dementia, Cognition and Learning, Healthcare, Vision, National Institute on Aging (NIA),

Released:
9-Jan-2020 10:30 AM EST
Research Results


8.40845